• International Media Acquisition Corp. entered an amended and restated merger agreement on April 30, 2026, revising terms of its previously disclosed business combination with VCI Holdings and related entities.
• Updated structure centers on Valix buying all VCI equity from VCI shareholders for 98,000,000 Purchaser Class A Ordinary Shares and 2,000,000 Purchaser Class B Ordinary Shares.
• Newbio Merger will then merge into International Media Acquisition Corp., leaving it as surviving entity and wholly owned subsidiary of Valix, followed by a conversion to a British Virgin Islands limited liability business company.
• Earnout shareholders could receive up to 27,000,000 additional Purchaser Class A Ordinary Shares tied to share-price, revenue, and dividend triggers over periods of up to five years post-closing.
• Completion remains subject to shareholder approvals at International Media Acquisition Corp. and VCI, alongside customary closing conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. International Media Acquisition Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-052267), on May 05, 2026, and is solely responsible for the information contained therein.